ClearPoint Neuro, Inc.: Business Overview, Financials & Competitive Analysis

ClearPoint Neuro, Inc. Overview

ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, providing both established clinical products and pre-clinical development services for controlled drug and device delivery. The company's key differentiator is its ability to conduct minimally invasive brain procedures under direct, intra-procedural MRI guidance, enhancing precision and safety.

Strategic Profile

ClearPoint Neuro has a technologically unique MRI-guided surgical platform creating a niche with high switching costs, with strength in recurring revenue from disposables and strategic partnerships in the high-potential biologics delivery market. The company achieved 18% year-over-year revenue growth in fiscal Q2 2026 (ended June 30, 2026), with neurosurgery navigation and therapy segment growing 62%, and management adjusted its 2026 full-year revenue guidance to between $48.0 million and $52.0 million.

Competitive Landscape

ClearPoint competes in a market dominated by large competitors, positioning itself as a niche player with differentiated MRI-guided technology. The primary competitive advantage lies in intra-procedural MRI guidance technology for minimally invasive brain surgery, which traditional navigation systems cannot match. Key competitors likely include larger medical device companies with neurosurgical portfolios and navigation technology providers.

Industry Context

ClearPoint Neuro, Inc. operates in Medical Devices.

Key facts

Founded: 1998 · Headquarters: Solana Beach, California, US · Employees: 172 · Revenue: Estimated $48.0M-$52.0M for fiscal year 2026 (full-year guidance as of Q2 2026)